INTRODUCTION AND HYPOTHESIS: This study is about evaluating safety and potential risk factors for complications following pelvic organ prolapse repair with the GYNECARE PROLIFT system. METHODS: This is a prospective observational study (Canadian Task Force II-1) performed in a tertiary referral center. A total of 114 women with pelvic organ prolapse, POP-Q stage ≥ 2, underwent a pelvic floor repair that included Prolift. RESULTS: During a mean follow-up time of 7 months there were six procedure failures (5.3%) and 14 mesh exposures (12.3%), more commonly on the anterior vaginal wall. Age was inversely related to the risk of having late mesh exposure (p = 0.02) with an odds ratio of 1.99 (95% confidence interval 1.10-3.59) for each decrease of 10 years in age. Late mesh exposure was significantly more common in sexually active patients (p = 0.016). CONCLUSIONS: Prolift repair has a high anatomical success rate. Young age and sexual activity are risk factors for mesh exposure.
INTRODUCTION AND HYPOTHESIS: This study is about evaluating safety and potential risk factors for complications following pelvic organ prolapse repair with the GYNECARE PROLIFT system. METHODS: This is a prospective observational study (Canadian Task Force II-1) performed in a tertiary referral center. A total of 114 women with pelvic organ prolapse, POP-Q stage ≥ 2, underwent a pelvic floor repair that included Prolift. RESULTS: During a mean follow-up time of 7 months there were six procedure failures (5.3%) and 14 mesh exposures (12.3%), more commonly on the anterior vaginal wall. Age was inversely related to the risk of having late mesh exposure (p = 0.02) with an odds ratio of 1.99 (95% confidence interval 1.10-3.59) for each decrease of 10 years in age. Late mesh exposure was significantly more common in sexually active patients (p = 0.016). CONCLUSIONS: Prolift repair has a high anatomical success rate. Young age and sexual activity are risk factors for mesh exposure.
Authors: R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith Journal: Am J Obstet Gynecol Date: 1996-07 Impact factor: 8.661
Authors: X Deffieux; R de Tayrac; C Huel; J Bottero; A Gervaise; K Bonnet; R Frydman; H Fernandez Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2006-01-04
Authors: P Debodinance; J Berrocal; H Clavé; M Cosson; O Garbin; B Jacquetin; C Rosenthal; D Salet-Lizée; R Villet Journal: J Gynecol Obstet Biol Reprod (Paris) Date: 2004-11
Authors: Karen P Gold; Renee M Ward; Carl W Zimmerman; Daniel H Biller; Shawn McGuinn; James C Slaughter; Roger R Dmochowski Journal: Int Urogynecol J Date: 2012-03-24 Impact factor: 2.894
Authors: J Farthmann; D Watermann; A Niesel; C Fünfgeld; A Kraus; F Lenz; H J Augenstein; E Graf; B Gabriel Journal: Int Urogynecol J Date: 2012-08-29 Impact factor: 2.894
Authors: Eoin MacCraith; Eoghan M Cunnane; Michael Joyce; James C Forde; Fergal J O'Brien; Niall F Davis Journal: Int Urogynecol J Date: 2020-11-25 Impact factor: 2.894